Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The influence of ApoE4 on clinical progression of dementia: a meta-analysis.

International journal of geriatric psychiatry - 1 May 2011

Allan Charlotte L, Ebmeier Klaus P

Abstract excerpt

OBJECTIVE: ApoE4 is a risk factor for the development of Alzheimer's disease, and has a functional role suggesting its importance in the neuropathology of dementia. We present a meta-analysis to investigate whether ApoE4 also affects the clinical progression of dementia in terms of cognitive decline or mortality. METHODS: We searched Medline, Embase and PsychINFO from 1990 until April 2009, for case control or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Biomarkers
Share to Dementia

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to Genetic Predisposition to Disease

Share to Risk Factors

Source

Identifiers

PMID: 20845403
DOI: 10.1002/gps.2559

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The influence of ApoE4 on clinical progression of dementia: a meta-analysis.PMID 20845403Read ↗

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.Semantic proximity Read ↗

Apolipoprotein ε4-allele as a significant risk factor for conversion from mild cognitive impairment to Alzheimer's disease: a meta-analysis of prospective studies.Semantic proximity Read ↗

Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.Semantic proximity Read ↗

APOE4 genotypes and the trajectory of biomarkers, neuroimaging, and cognitive measures in Alzheimer's Disease: A mixed-effects disease progression model.Semantic proximity Read ↗

Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.Semantic proximity Read ↗

Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease.Semantic proximity Read ↗

The role of dementia in the association between APOE4 and all-cause mortality: pooled analyses of two population-based cohort studies.Semantic proximity Read ↗

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.Semantic proximity Read ↗

Age‐dependent effects of <i>APOE</i> ε4 in preclinical Alzheimer's diseaseSemantic proximity Read ↗

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's diseaseSemantic proximity Read ↗

Association between apolipoprotein E ε4 status and the risk of Alzheimer's disease: a meta-analysis.Semantic proximity Read ↗

Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.